Nothing Special   »   [go: up one dir, main page]

Kawaguchi Y, Kubota Y. (1993). Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. Journal of neurophysiology. 70 [PubMed]

See more from authors: Kawaguchi Y · Kubota Y

References and models cited by this paper
References and models that cite this paper

Helmstaedter M, Sakmann B, Feldmeyer D. (2009). The relation between dendritic geometry, electrical excitability, and axonal projections of L2/3 interneurons in rat barrel cortex. Cerebral cortex (New York, N.Y. : 1991). 19 [PubMed]

Komarov M, Bazhenov M. (2016). Linking dynamics of the inhibitory network to the input structure. Journal of computational neuroscience. 41 [PubMed]

Konstantoudaki X, Papoutsi A, Chalkiadaki K, Poirazi P, Sidiropoulou K. (2014). Modulatory effects of inhibition on persistent activity in a cortical microcircuit model. Frontiers in neural circuits. 8 [PubMed]

Lundqvist M, Rehn M, Djurfeldt M, Lansner A. (2006). Attractor dynamics in a modular network model of neocortex. Network (Bristol, England). 17 [PubMed]

Markram H et al. (2015). Reconstruction and Simulation of Neocortical Microcircuitry. Cell. 163 [PubMed]

Papoutsi A, Sidiropoulou K, Cutsuridis V, Poirazi P. (2013). Induction and modulation of persistent activity in a layer V PFC microcircuit model. Frontiers in neural circuits. 7 [PubMed]

Soltesz I, Smetters DK, Mody I. (1995). Tonic inhibition originates from synapses close to the soma. Neuron. 14 [PubMed]

Xiang Z, Huguenard JR, Prince DA. (2002). Synaptic inhibition of pyramidal cells evoked by different interneuronal subtypes in layer v of rat visual cortex. Journal of neurophysiology. 88 [PubMed]

Yang CR, Seamans JK, Gorelova N. (1999). Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 21 [PubMed]

This website requires cookies and limited processing of your personal data in order to function. By continuing to browse or otherwise use this site, you are agreeing to this use. See our Privacy policy and how to cite and terms of use.